AIIA launches ‘Ayush Start-up Challenge’
AIIA partners with Startup India with the aim to identify and support innovations and start-ups working in the Ayush sector
AIIA partners with Startup India with the aim to identify and support innovations and start-ups working in the Ayush sector
CEPI is accelerating its programme to develop broadly protective coronavirus vaccines—a core part of US $ 3.5 billion pandemic preparedness plan
The immunogens being tested in IAVI G002 were developed by scientific teams at IAVI and Scripps Research and will be delivered via Moderna's mRNA technology
The R&D centre will endeavour to bring scientifically advanced biological, biotechnology products and novel drug delivery systems
First-of-its-kind Incubator will support companies poised to deliver breakthrough applications in genomics and multiomics
The 462,000 square foot state-of-the-art building targeting LEED Zero certification and is designed to be the most sustainable commercial lab building in Cambridge
This award is open to all currently operational laboratories pertaining to testing, calibration & medical including their proficiency testing providers & reference material producers located in India
The first quarter performance reflects growth across all its business divisions as the company continued to operate at normal levels
Broadens company’s oncology platform of Targeted Alpha Therapies (TATs)
The DREAM-ND Phase III trial has now enrolled 588 CKD patients not-on-dialysis.
Subscribe To Our Newsletter & Stay Updated